Saccharomyces cerevisiae infections in man

Clicks: 341
ID: 265690
1984
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 2 articles by views in Sabouraudia

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Saccharomyces cerevisiae is a yeast commonly used to make food products such as bread, beer and wine, or ingested whole as a 'health' food. We report five cases of infections involving S. cerevisiae, including one in which S. cerevisiae alone was implicated, and review the literature on its pathogen …
Reference Key
rh1984sabouraudiasaccharomyces Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Eng RH;Drehmel R;Smith SM;Goldstein EJ;;
Journal Sabouraudia
Year 1984
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/6390738
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine esophagitis / etiology research support u.s. gov't non-p.h.s. male case reports aged middle aged e j goldstein pressure ulcer / complications mycoses / etiology* pmid:6390738 r h eng r drehmel pleural effusion / etiology saccharomyces cerevisiae / isolation & purification saccharomyces cerevisiae / pathogenicity* urethral diseases / etiology urinary fistula / etiology urinary tract infections / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.